Research Article
Urinary Exosomal Long Noncoding RNA TERC as a Noninvasive Diagnostic and Prognostic Biomarker for Bladder Urothelial Carcinoma
Figure 5
Analysis of Kaplan–Meier survival curves from the PrognoScan database. (a) The disease-specific survival (DSS) curve of TERC (hazard ratio [HR]: 1.79, 95% confidence interval [CI]: 1.12–2.88, ). (b) The overall survival (OS) curve of TERC (HR: 1.51, 95% CI: 0.95–2.39, ). indicates a risk factor associated with poor patient outcomes.
(a) |
(b) |